Teva Pharmaceutical Industries
Copaxone may protect against axonal injury over the long-term
Published in Medical Imaging Law Weekly, August 2nd, 2005
Results highlighted sustained beneficial effects on cerebral axonal injury and the value of starting Copaxone treatment early to slow the accumulation of long-term disability as measured by the Expanded Disability Status Scale (EDSS).
Brain n-acetyl aspartate (NAA) levels, a marker of neuronal integrity and function, are measured by magnetic resonance spectroscopy (MRS). An increase in brain NAA levels...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Law Weekly
More Articles from Medical Imaging Law Weekly
- Ardmore Development Authority
Ardmore Technology Transfer Center opens - Erasmus Medical Center
4-D Multislice CT useful in assessing respiratory lung tumor motion - MIT, Charlestown
Age-related changes in white matter microstructure characterized - Siemens Medical Solutions
Angio CT Miyabi provides better care for patients in case of an emergency - Acibadem Hastanesi, Istanbul
Strain measurement during dobutamine infusion may provide FFR information - Advanced Medical Solutions Group plc
Superglue product launched for closing keyhole surgery wounds - More from this issue of Medical Imaging Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
